We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+16.94%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$668M
AUM Growth
+$522M
(+358%)
Cap. Flow
+$525M
Cap. Flow
% of AUM
78.56%
Top 10 Holdings %
Top 10 Hldgs %
88.26%
Holding
121
New
33
Increased
13
Reduced
29
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teekay
TK
|
+$13M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
+$2.93M |
| 3 |
Nokia
NOK
|
+$2.85M |
| 4 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$2.79M |
| 5 |
Las Vegas Sands
LVS
|
+$2.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.31M |
| 2 |
AXON
Axon Enterprise
AXON
|
+$3.3M |
| 3 |
XENT
Intersect ENT, Inc
XENT
|
+$2.62M |
| 4 |
Protolabs
PRLB
|
+$2.44M |
| 5 |
ADPT
Adeptus Health Inc
ADPT
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.35% |
| 2 | Technology | 3.13% |
| 3 | Consumer Discretionary | 2.09% |
| 4 | Communication Services | 1.14% |
| 5 | Consumer Staples | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $518M | 77.52% |
+2,540,000
| New | +$522M |
|
2
PUT
Invesco QQQ Trust
QQQ
$455B
| $33.6M | 5.02% |
+300,000
| New | +$33.5M |
|
|
NVRO
3
DELISTED
NEVRO CORP.
NVRO
| $8.44M | 1.26% |
125,000
+9,073
| +8% | +$486K |
|
4
Meta Platforms (Facebook)
META
$1.51T
| $6.09M | 0.91% |
58,200
-1,800
| -3% | -$185K |
|
|
5
Teekay
TK
$975M
| $4.93M | 0.74% |
+500,000
| New | +$13M |
|
|
HIMX
6
Himax Technologies
HIMX
$2.2B
| $4.1M | 0.61% |
500,000
-143,952
| -22% | -$1.04M |
|
|
ADPT
7
DELISTED
Adeptus Health Inc
ADPT
| $4.09M | 0.61% |
75,000
-23,845
| -24% | -$1.52M |
|
|
ARIA
8
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.63M | 0.54% |
581,215
-53,557
| -8% | -$351K |
|
|
LOCK
9
DELISTED
LifeLock, Inc.
LOCK
| $3.63M | 0.54% |
252,945
+158,617
| +168% | +$2.04M |
|
|
AERI
10
DELISTED
Aerie Pharmaceuticals
AERI
| $3.29M | 0.49% |
135,000
+65,000
| +93% | +$1.52M |
|
|
11
Enanta Pharmaceuticals
ENTA
$372M
| $2.97M | 0.44% |
+90,000
| New | +$2.93M |
|
|
ADMS
12
DELISTED
Adamas Pharmaceuticals
ADMS
| $2.85M | 0.43% |
100,631
+45,000
| +81% | +$758K |
|
|
IDTI
13
DELISTED
Integrated Device Technology I
IDTI
| $2.85M | 0.43% |
108,000
+48,000
| +80% | +$1.23M |
|
|
14
Nokia
NOK
$50.8B
| $2.81M | 0.42% |
+400,000
| New | +$2.85M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $2.73M | 0.41% |
22,778
+8,580
| +60% | +$993K |
|
|
SBBP
16
DELISTED
Strongbridge Biopharma plc.
SBBP
| $2.68M | 0.4% |
+388,945
| New | +$2.79M |
|
17
Amazon
AMZN
$2.5T
| $2.56M | 0.38% |
75,600
-8,400
| -10% | -$265K |
|
|
18
Las Vegas Sands
LVS
$30.5B
| $2.43M | 0.36% |
+55,500
| New | +$2.52M |
|
|
MNK
19
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $2.24M | 0.34% |
+30,000
| New | +$2.02M |
|
20
General Motors
GM
$74.7B
| $2.21M | 0.33% |
65,000
+20,000
| +44% | +$695K |
|
|
CBPO
21
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $2.18M | 0.33% |
15,300
-4,700
| -24% | -$543K |
|
|
DOC
22
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.06M | 0.31% |
122,227
-13,581
| -10% | -$216K |
|
23
Bausch Health
BHC
$1.65B
| $2.03M | 0.3% |
+20,000
| New | +$2.25M |
|
24
Alibaba
BABA
$269B
| $1.99M | 0.3% |
+24,500
| New | +$1.92M |
|
|
FPRX
25
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.91M | 0.29% |
+45,900
| New | +$1.54M |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Granite Point Capital Management held 121 positions worth $668M, up 358% from $146M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Granite Point Capital Management deployed $525M of net new capital in Q4 2015, opening 33 new positions and adding to 13 existing holdings. Its largest new stake was Teekay: 500,000 shares worth $4.93M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Intersect ENT, Inc, an estimated $2.62M trimmed.
- Granite Point Capital Management's largest Q4 2015 buy was Teekay: 500,000 shares worth $4.93M.
- Granite Point Capital Management added most to LifeLock, Inc. in Q4 2015, an estimated $2.04M increase.
- Granite Point Capital Management's biggest Q4 2015 reduction was Intersect ENT, Inc, cutting an estimated $2.62M.
- Granite Point Capital Management fully exited Apple in Q4 2015, selling an estimated $3.31M.
- Granite Point Capital Management's ten largest holdings make up 88% of its $668M portfolio in Q4 2015.
- Granite Point Capital Management opened 33 new positions and closed 41 in Q4 2015.
- Granite Point Capital Management's portfolio value rose 358% quarter-over-quarter to $668M.
Based on Granite Point Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.